Increased rate of osteoporosis, low lean mass, and fragility fractures in COPD patients: association with disease severity

  • R. Q. Graumam
  • M. M. Pinheiro
  • L. E. Nery
  • C.H.M. Castro
Original Article

Abstract

Summary

A very high rate of osteoporosis, fractures, and low lean mass was observed in patients with chronic obstructive pulmonary disease (COPD). Disease severity was associated with bone and muscle adverse outcomes, while age ≥ 63.5 years old, low lean mass, higher iPTH, and a T-score below − 2.5 were all associated with higher risk of fracture.

Introduction

Osteoporosis is frequently neglected in patients with COPD. We aimed at evaluating the rate of osteoporosis, fractures, and low lean mass in patients with COPD.

Methods

Ninety-nine patients with COPD (53 women, 64.5 ± 9.6 years old, and 46 men, 65.9 ± 8.0 years old) underwent bone densitometry (DXA) with body composition analyses. Healthy individuals (N = 57) not exposed to tobacco matched by sex, age, and body mass index (BMI) were used as controls. Spirometry, routine laboratory workout, and conventional thoracolumbar radiography surveying for vertebral deformities were performed in all patients.

Results

Osteoporosis was found in 40.4% of the COPD patients against only 13.0% of the healthy controls (p = 0.001). Vertebral fractures were seen in 24.4% of the men and 22.0% of the women with COPD. Disease severity (GOLD 3 and 4) was significantly associated with higher risk of vitamin D deficiency (p = 0.032), lower BMD (both men and women at all sites), higher frequency of osteoporosis (in women at all sites), lower skeletal mass index, and higher rate of low lean mass (in both men and women) than healthy controls and COPD patients with milder disease (GOLD 1 and 2). Age was a main predictor of vertebral fractures (OR = 1.164 (1.078–9.297); p < 0.001), while high plasma iPTH (OR = 1.045 (1.005–1.088); p = 0.029) and low ALM (OR = 0.99965 (0.99933–0.99997); p = 0.031) were predictors of non-vertebral fractures.

Conclusion

Highly prevalent in COPD, osteoporosis and low lean mass were associated with FEV1% < 50%. Age, low lean mass, high iPTH, and low bone mass were all significantly associated with fractures in COPD patients.

Keywords

BMD Chronic obstructive pulmonary disease FEV1 Fragility fractures Lean mass Osteoporosis 

Notes

Compliance with ethical standards

Conflicts of interest

None.

Supplementary material

198_2018_4483_MOESM1_ESM.docx (245 kb)
Supplemental Fig. 1 (DOCX 244 kb)

References

  1. 1.
    Vogelmeier CF, Criner GJ, Martinez FJ, Anzueto A, Barnes PJ, Bourbeau J, Celli BR, Chen R, Decramer M, Fabbri LM, Frith P, Halpin DMG, López Varela MV, Nishimura M, Roche N, Rodriguez-Roisin R, Sin DD, Singh D, Stockley R, Vestbo J, Wedzicha JA, Agusti A (2017) Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report: GOLD executive summary. Eur Respir J 49:1700214CrossRefPubMedGoogle Scholar
  2. 2.
    Schwab P, Dhamane AD, Hopson SD, Moretz C, Annavarapu S, Burslem K, Renda A, Kaila S (2017) Impact of comorbid conditions in COPD patients on health care resource utilization and costs in a predominantly Medicare population. Int J Chron Obstruct Pulmon Dis 12:735–744CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Silva DR, Coelho AC, Dumke A, Valentini JD, de Nunes JN, Stefani CL, da Silva Mendes LF, Knorst MM (2011) Osteoporosis prevalence and associated factors in patients with COPD: a cross-sectional study. Respir Care 56:961–968CrossRefPubMedGoogle Scholar
  4. 4.
    Dam TT, Harrison S, Fink HA, Ramsdell J, Barrett-Connor E, Osteoporotic fractures in men research G (2010) Bone mineral density and fractures in older men with chronic obstructive pulmonary disease or asthma. Osteoporos Int 21:1341–1349CrossRefPubMedGoogle Scholar
  5. 5.
    Pascual-Guardia S, Badenes-Bonet D, Martin-Ontiyuelo C, Zuccarino F, Marin-Corral J, Rodriguez A, Barreiro E, Gea J (2017) Hospital admissions and mortality in patients with COPD exacerbations and vertebral body compression fractures. Int J Chron Obstruct Pulmon Dis 12:1837–1845CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Harrison RA, Siminoski K, Vethanayagam D, Majumdar SR (2007) Osteoporosis-related kyphosis and impairments in pulmonary function: a systematic review. J Bone and Mineral Res : Off J Am Soc Bone and Mineral Res 22:447–457CrossRefGoogle Scholar
  7. 7.
    Graat-Verboom L, Spruit MA, van den Borne BE, Smeenk FW, Martens EJ, Lunde R, Wouters EF, Network C (2009) Correlates of osteoporosis in chronic obstructive pulmonary disease: an underestimated systemic component. Respir Med 103:1143–1151CrossRefPubMedGoogle Scholar
  8. 8.
    Okazaki R, Watanabe R, Inoue D (2016) Osteoporosis associated with chronic obstructive pulmonary disease. J Bone metab 23:111–120CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    NIH Consensus Development Panel on Osteoporosis Prevention D, Therapy (2001) Osteoporosis prevention, diagnosis, and therapy. JAMA : J Am Med Assoc 285:785–795Google Scholar
  10. 10.
    Graat-Verboom L, van den Borne BE, Smeenk FW, Spruit MA, Wouters EF (2011) Osteoporosis in COPD outpatients based on bone mineral density and vertebral fractures. J Bone Miner Res 26:561–568CrossRefPubMedGoogle Scholar
  11. 11.
    Sozen T, Ozisik L, Basaran NC (2017) An overview and management of osteoporosis. Eur J Rheumatol 4:46–56Google Scholar
  12. 12.
    Buist AS, Vollmer WM, McBurnie MA (2008) Worldwide burden of COPD in high- and low-income countries. Part I. The burden of obstructive lung disease (BOLD) initiative. Int J Tuberc Lung Dis 12:703–708PubMedGoogle Scholar
  13. 13.
    Ferguson GT, Calverley PM, Anderson JA, Jenkins CR, Jones PW, Willits LR, Yates JC, Vestbo J, Celli B (2009) Prevalence and progression of osteoporosis in patients with COPD: results from the TOwards a revolution in COPD health study. Chest 136:1456–1465CrossRefPubMedGoogle Scholar
  14. 14.
    Briot K, Geusens P, Em Bultink I, Lems WF, Roux C (2017) Inflammatory diseases and bone fragility. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USAGoogle Scholar
  15. 15.
    Pinheiro MM, Ciconelli RM, Martini LA, Ferraz MB (2009) Clinical risk factors for osteoporotic fractures in Brazilian women and men: the Brazilian osteoporosis study (BRAZOS). Osteoporos Int : J Established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20:399–408CrossRefGoogle Scholar
  16. 16.
    Lewiecki EM, Gordon CM, Baim S, Leonard MB, Bishop NJ, Bianchi ML, Kalkwarf HJ, Langman CB, Plotkin H, Rauch F, Zemel BS, Binkley N, Bilezikian JP, Kendler DL, Hans DB, Silverman S (2008) International Society for Clinical Densitometry 2007 adult and pediatric official positions. Bone 43:1115–1121CrossRefPubMedGoogle Scholar
  17. 17.
    Baumgartner RN, Koehler KM, Gallagher D, Romero L, Heymsfield SB, Ross RR, Garry PJ, Lindeman RD (1998) Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol 147:755–763CrossRefPubMedGoogle Scholar
  18. 18.
    Gluer CC, Blake G, Lu Y, Blunt BA, Jergas M, Genant HK (1995) Accurate assessment of precision errors: how to measure the reproducibility of bone densitometry techniques. Osteoporosis International : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 5:262–270CrossRefGoogle Scholar
  19. 19.
    Sousa MD, Pinheiro MM, Szejnfeld VL, Castro CH (2013) Body composition parameters in healthy Brazilian women differ from White, Black, and Hispanic American women reference range. Journal of clinical densitometry : the official journal of the International Society for Clinical DensitometryGoogle Scholar
  20. 20.
    Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, Martin FC, Michel JP, Rolland Y, Schneider SM, Topinková E, Vandewoude M, Zamboni M, European Working Group on Sarcopenia in Older People (2010) Sarcopenia: European consensus on definition and diagnosis: report of the European working group on sarcopenia in older people. Age Ageing 39:412–423CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Studenski SA, Peters KW, Alley DE, Cawthon PM, McLean RR, Harris TB, Ferrucci L, Guralnik JM, Fragala MS, Kenny AM, Kiel DP, Kritchevsky SB, Shardell MD, Dam TTL, Vassileva MT (2014) The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates. J Gerontol A Biol Sci Med Sci 69:547–558CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Vestbo J, Hurd SS, Agusti AG et al (2013) Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 187:347–365CrossRefPubMedGoogle Scholar
  23. 23.
    Genant HK, Wu CY, van Kuijk C, Nevitt MC (1993) Vertebral fracture assessment using a semiquantitative technique. J Bone and Mineral Res : Off J Am Soc Bone and Mineral Res 8:1137–1148CrossRefGoogle Scholar
  24. 24.
    Kanis JA (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. WHO study group. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 4:368–381CrossRefGoogle Scholar
  25. 25.
    Podsiadlo D, Richardson S (1991) The timed “Up & Go”: a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc 39:142–148CrossRefPubMedGoogle Scholar
  26. 26.
    Baecke JA, Burema J, Frijters JE (1982) A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr 36:936–942CrossRefPubMedGoogle Scholar
  27. 27.
    Eloi M, Horvath DV, Szejnfeld VL, Ortega JC, Rocha DA, Szejnfeld J, Castro CH (2016) Vitamin D deficiency and seasonal variation over the years in Sao Paulo, Brazil. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 27:3449–3456CrossRefGoogle Scholar
  28. 28.
    Eloi M, Horvath DV, Ortega JC, Prado MS, Andrade LE, Szejnfeld VL, de Moura Castro CH (2017) 25-Hydroxivitamin D serum concentration, not free and bioavailable vitamin D, is associated with disease activity in systemic lupus erythematosus patients. PLoS One 12:e0170323CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Arantes HP, Gimeno SG, Chiang AY, Bilezikian JP, Lazaretti-Castro M (2016) Incidence of vertebral fractures in calcium and vitamin D-supplemented postmenopausal Brazilian women with osteopenia or osteoporosis: data from Arzoxifene generations trial. Arch Endocrinol Metab 60:54–59CrossRefPubMedGoogle Scholar
  30. 30.
    Ballane G, Cauley JA, Luckey MM, El-Hajj Fuleihan G (2017) Worldwide prevalence and incidence of osteoporotic vertebral fractures. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 28:1531–1542CrossRefGoogle Scholar
  31. 31.
    Lopes JB, Danilevicius CF, Takayama L, Caparbo VF, Menezes PR, Scazufca M, Kuroishi ME, Pereira RM (2011) Prevalence and risk factors of radiographic vertebral fracture in Brazilian community-dwelling elderly. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 22:711–719CrossRefGoogle Scholar
  32. 32.
    Fouda MA, Alhamad EH, Al-Hajjaj MS, Shaik SA, Alboukai AA, Al-Kassimi FA (2017) A study of chronic obstructive pulmonary disease-specific causes of osteoporosis with emphasis on the emphysema phenotype. Ann Thorac Med 12:101–106CrossRefPubMedPubMedCentralGoogle Scholar
  33. 33.
    Eisner MD, Blanc PD, Sidney S, Yelin EH, Lathon PV, Katz PP, Tolstykh I, Ackerson L, Iribarren C (2007) Body composition and functional limitation in COPD. Respir Res 8:7CrossRefPubMedPubMedCentralGoogle Scholar
  34. 34.
    Napoli N, Chandran M, Pierroz DD, Abrahamsen B, Schwartz AV, Ferrari SL, Bone IOF, Diabetes Working G (2016) Mechanisms of diabetes mellitus-induced bone fragility. Nat Rev EndocrinolGoogle Scholar
  35. 35.
    Lorbergs AL, O'Connor GT, Zhou Y, Travison TG, Kiel DP, Cupples LA, Rosen H, Samelson EJ (2017) Severity of kyphosis and decline in lung function: the Framingham study. J Gerontol series Biol Sci Med Sci 72:689–694Google Scholar
  36. 36.
    Holick MF (2017) The vitamin D deficiency pandemic: approaches for diagnosis, treatment and prevention. Rev Endocrine Metab Disorders 18:153–165CrossRefGoogle Scholar
  37. 37.
    Trochoutsou AI, Kloukina V, Samitas K, Xanthou G (2015) Vitamin-D in the immune system: genomic and non-genomic actions. Mini Rev Med Chem 15:953–963CrossRefPubMedGoogle Scholar
  38. 38.
    Kokturk N, Baha A, Oh YM, Young Ju J, Jones PW (2016) Vitamin D deficiency: what does it mean for chronic obstructive pulmonary disease (COPD)? A comprehensive review for pulmonologists. Clin Respir JGoogle Scholar
  39. 39.
    Zhu M, Wang T, Wang C, Ji Y (2016) The association between vitamin D and COPD risk, severity, and exacerbation: an updated systematic review and meta-analysis. Int J Chron Obstruct Pulmon Dis 11:2597–2607CrossRefPubMedPubMedCentralGoogle Scholar
  40. 40.
    Autier P, Boniol M, Pizot C, Mullie P (2014) Vitamin D status and ill health: a systematic review. Lancet Diabetes Endocrinol 2:76–89CrossRefPubMedGoogle Scholar
  41. 41.
    Park JH, Park HK, Jung H, Lee SS, Koo HK (2015) Parathyroid hormone as a novel biomarker for chronic obstructive pulmonary disease: Korean National Health and nutrition examination survey. PLoS One 10:e0138482CrossRefPubMedPubMedCentralGoogle Scholar
  42. 42.
    Mesquita R, Wilke S, Smid DE, Janssen DJ, Franssen FM, Probst VS, Wouters EF, Muris JW, Pitta F, Spruit MA (2016) Measurement properties of the Timed Up & Go test in patients with COPD. Chron Respir DisGoogle Scholar
  43. 43.
    Franco CB, Paz-Filho G, Gomes PE, Nascimento VB, Kulak CA, Boguszewski CL, Borba VZ (2009) Chronic obstructive pulmonary disease is associated with osteoporosis and low levels of vitamin D. Osteoporos Int 20:1881–1887CrossRefPubMedGoogle Scholar
  44. 44.
    Camiciottoli G, Bigazzi F, Magni C, Bonti V, Diciotti S, Bartolucci M, Mascalchi M, Pistolesi M (2016) Prevalence of comorbidities according to predominant phenotype and severity of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 11:2229–2236CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© International Osteoporosis Foundation and National Osteoporosis Foundation 2018

Authors and Affiliations

  • R. Q. Graumam
    • 1
  • M. M. Pinheiro
    • 1
  • L. E. Nery
    • 2
  • C.H.M. Castro
    • 1
  1. 1.Rheumatology DivisionEscola Paulista de Medicina/Universidade Federal de São Paulo (EPM/UNIFESP)São PauloBrazil
  2. 2.Pulmonology DivisionEscola Paulista de Medicina/Universidade Federal de São Paulo (EPM/UNIFESP)São PauloBrazil

Personalised recommendations